Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchospasm: prevention and treatment.

P Ghiringhelli

    International Journal of Clinical Pharmacology, Therapy, and Toxicology
    |January 1, 1985
    PubMed
    Summary

    A combination of salbutamol and oxatomide effectively treated bronchospasm in 95% of patients. This combination improved respiratory status and prevented dyspnea attacks, with no side effects observed in the study.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patient re-training in peritoneal dialysis: why and when it is needed.

    Kidney international. Supplement·2006
    Same author

    [Temporomandibular joint involvement in juvenile idiopathic arthritis: treatment with an orthodontic appliance].

    Reumatismo·2005
    Same author

    [Adult-onset Still's disease. Report of 5 cases].

    Minerva medica·1999
    Same author

    Chronic pancreatitis associated with membranous glomerulonephritis.

    Clinical nephrology·1998
    Same author

    Membranoproliferative glomerulonephritis secondary to tuberculosis.

    Clinical nephrology·1997
    Same author

    Vasculitis involving lung, toes and kidneys in a patient with angioedema: a common pathogenesis?

    Clinical nephrology·1993

    Area of Science:

    • Pulmonology
    • Pharmacology

    Background:

    • Bronchospastic conditions significantly impact patient respiratory status and quality of life.
    • Salbutamol is a common bronchodilator, but its efficacy can be limited in severe cases.

    Purpose of the Study:

    • To evaluate the efficacy and tolerability of an extempore combination of salbutamol and oxatomide versus salbutamol alone in treating bronchospastic conditions.

    Main Methods:

    • A comparative study involving two groups of 20 patients with bronchospastic conditions.
    • Group 1 received a combination of salbutamol (2 mg) and oxatomide (30 mg) tablets.
    • Group 2 received salbutamol (2 mg) tablets alone.

    Main Results:

    • The combination therapy achieved positive results in 95% of patients, compared to 55% with salbutamol alone.
    • Treatment with the combination led to bronchospasm resolution, prevention of dyspnea attacks, and improved respiratory status.
    • The combination was well-tolerated with no side effects; salbutamol alone caused mild tremors and tachycardia in 3 patients.

    Conclusions:

    • The combination of salbutamol and oxatomide is a highly effective and well-tolerated treatment for bronchospastic conditions.
    • This combination offers significant advantages over salbutamol monotherapy in managing respiratory distress and improving patient outcomes.

    Related Experiment Videos